News and Trends-Mabnus

2024-04-24

Previously, we introduced the regulatory protein CD35 (CR1) in the complement system. In this issue, we will introduce another complement system regulatory protein CD55. CD55 is th...

Therapeutic target for multiple myeloma CD38

2024-04-24

CD38 is a transmembrane glycoprotein with exoenzyme activity that also functions as a receptor and adhesion molecule. CD38 is expressed at low levels in normal lymphocytes, myeloid...

Detection of small molecule ethylpyrimol residues in agricultural products and environment

2024-04-24

Background:Ethylpyrimidine, a typical pyrimidine fungicide, has been widely used for over 50 years to control powdery mildew on various fruits and vegetables. Excessive use of ethy...

Functional IgG-like stability and pharmacological studies of tetravalent bispecific antibodies

2024-04-23

BackgroundBispecific antibodies (bsAbs) are a promising drug modality that can simultaneously bind to two distinct epitopes on the same or different antigens. So far, 14 bsAb drugs...

The scavenger receptor CD36

2024-04-18

CD36 is a scavenger receptor expressed in multiple cell types that mediates lipid uptake, immune recognition, inflammation, molecular adhesion and cell apoptosis. It plays an impor...

CD33 is a potential therapeutic target

2024-04-16

CD33 is a cell surface protein belonging to the sialic acid-binding immunoglobulin-like lectins (Siglecs) family. It is a transmembrane protein that plays an important role in medi...

The complement receptor CD35

2024-04-15

CD35, also known as complement receptor 1 (CR1), plays a crucial role in the complement system. The complement system is part of the immune system and, through a series of cascades...